ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,010.60
      0.87%
      US Tech 100
      16,752.80
      0.00%
      Dow Jones
      38,239.98
      0.67%
      Brent Oil
      86.825
      0.48%
      Bitcoin
      66,111.94
      -1.11%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Qiagen NV (QGEN)

      7. Qiagen NV (QGEN) News

      QGEN Qiagen NV

      41.22
      0.00 (0.00%)
      Apr 22 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Qiagen NV QGEN NYSE Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 41.22 20:00:00
      Open Price Low Price High Price Close Price Prev Close
      41.22
      more quote information »

      Recent News

      Date Time Source Heading
      4/22/20248:49IHNWFeaturedCannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California
      4/09/202409:48GLOBEQIAGEN N.V. to release results for Q1 2024 and hold webcast
      4/03/202416:05GLOBEQIAGEN strengthens its portfolio for cancer research,..
      3/25/202416:05GLOBEQIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test..
      3/18/202416:05GLOBEQIAGEN partners with International Panel Physicians..
      3/11/202405:59GLOBEQIAGEN announces Form 20-F annual report filing for 2023..
      2/27/202417:44GLOBEQIAGEN launches AI-derived biomedical knowledge base to..
      2/27/202416:05GLOBEQIAGEN earns ACT Label for new eco-friendlier QIAwave..
      2/15/202416:05GLOBEQIAGEN earns ACT Label for new eco-friendlier QIAwave..
      2/08/202409:47EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      2/06/202416:05GLOBEQIAGEN exceeds outlook for Q4 2023, led by 8% CER sales..
      1/25/202410:00GLOBEQIAGEN announces partnership with Penn State University to..
      1/23/202416:13EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      1/18/202416:05GLOBEQIAGEN announces details for completion of synthetic share..
      1/11/202407:53GLOBEQIAGEN N.V. to release results for Q4 2023 and hold webcast
      1/08/202409:59EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/08/202402:00GLOBEQIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use..
      1/07/202413:07GLOBEQIAGEN announces plans to return approximately $300 million..
      1/04/202416:05GLOBEQIAGEN to accelerate investments into QIAGEN Digital..
      1/03/202402:00GLOBEQIAGEN expands business in Middle East with new regional..
      11/30/202316:05GLOBEDNA Labs International solves significant cold cases with..
      11/15/202316:05GLOBEQIAGEN launches TissueLyser III and RNeasy PowerMax Soil Pro..
      11/09/202316:05GLOBEQIAGEN launches new QIAcuity digital PCR kits and updated..
      11/06/202316:05GLOBEQIAGEN launches complete Sample to Insight workflow for..
      11/02/202308:00PRNUSQIAGEN and Element Biosciences partner to offer complete..
      10/30/202316:05GLOBEQIAGEN exceeds outlook for Q3 2023 with 5% CER sales growth..
      10/26/202308:00GLOBEQIAGEN and Myriad Genetics partner to advance companion..
      10/09/202311:14GLOBEQIAGEN N.V. to release results for Q3 2023 and hold webcast
      10/04/202316:05GLOBEQIAGEN launches QuantiFERON-EBV RUO assay, facilitating..
      9/28/202316:05GLOBEQIAGEN extends AI capabilities of its NGS interpretation..
      9/27/202316:05GLOBEQIAGEN reports progress toward achieving Environmental,..
      9/25/202316:05GLOBEQIAGEN enhances QIAwave portfolio with new eco-friendlier..
      8/25/202316:48EDGAR2Form 144 - Report of proposed sale of securities
      8/09/202321:55EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      8/09/202321:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      8/08/202316:05GLOBEQIAGEN delivers ahead of outlook for Q2 2023 with 9% CER..
      8/07/202316:05GLOBEQIAGEN receives FDA approval for companion diagnostic to..
      7/26/202316:15BWBio-Rad and QIAGEN Announce Patent Settlement and..
      7/24/202307:41GLOBEQIAGEN N.V. to release results for Q2 2023 and hold webcast
      7/18/202316:05GLOBEQIAGEN expands range of digital PCR kits and services for..
      6/20/202316:05GLOBEFBI approves QIAGEN’s NGS-based ForenSeq MainstAY workflow..
      6/16/202307:36GLOBEQIAGEN provides reminder on settlement mechanics of 2023 and..
      6/15/202316:05GLOBEQIAGEN’s QuantiFERON-TB Gold Plus shows unique clinical..
      6/13/202316:05GLOBEDanish National Genome Center selects QIAGEN for variant..
      5/03/202316:05GLOBEQIAGEN exceeds outlook for Q1 2023 with 12% CER sales growth..
      5/03/202305:30GLOBEQIAGEN welcomes U.S. Preventive Services Task Force..
      4/24/202316:05GLOBEQIAGEN launches QIAstat-Dx in Japan with respiratory panel..

      Your Recent History

      NYSE
      QGEN
      Qiagen NV
      Delayed Upgrade Clock